ONE-WAYOngoing theme · still written in the latest filings
Hybrid growth model combining marketed products and a clinical pipeline
A growth strategy to transition from a business model focused on early-stage drug discovery to a “platform plus portfolio” model combining a revenue base from marketed products with a clinical-stage pipeline.
Companies2How many companies write about this.
Threads2One company can carry more than one thread here.